• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

75048例2型糖尿病患者的血脂情况:一项基于瑞典国家糖尿病登记处的人群调查。

Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register.

作者信息

Eriksson Mats, Zethelius Björn, Eeg-Olofsson Katarina, Nilsson Peter M, Gudbjörnsdottir Soffia, Cederholm Jan, Eliasson Björn

机构信息

Department of Medicine, Centre for Metabolism and Endocrinology, Karolinska Institute at Karolinska University Hospital, Huddinge, Sweden.

出版信息

Eur J Cardiovasc Prev Rehabil. 2011 Feb;18(1):97-105. doi: 10.1097/HJR.0b013e32833ba61e.

DOI:10.1097/HJR.0b013e32833ba61e
PMID:21354969
Abstract

BACKGROUND

Type 2 diabetes and diabetic dyslipidemia are high-risk conditions for cardiovascular disease. However, the description of the distribution of blood lipids in diabetic patients has not been based on population-based surveys. The aim of this study was to describe diabetic dyslipidemia in a large unselected sample of patients from the Swedish National Diabetes Register.

METHODS

Blood lipid profiles and clinical characteristics in 75,048 type 2 diabetic patients (57% men) were studied.

RESULTS

Pronounced hypertriglyceridemia (triglycerides >4.0mmol/l) was seen in 3.4% of the patients. Total cholesterol (TC), LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C) and non-HDL-C were generally higher, and LDL-C/HDL-C and Non-HDL-C/HDL-C ratios were lower in women. Mean TC, LDL-C as well as HDL-C values were lower in patients treated with lipid-lowering agents, whereas triglycerides was higher than in the untreated patients. In patients not treated with lipid-lowering agents all blood lipids increased in women and decreased in men (except HDL-C) at higher ages. Patients with LDL-C/HDL-C ratio ≥ 3 were slightly younger, less frequently used lipid-lowering drugs and had not so often a history of coronary heart disease or stroke.

CONCLUSION

The distribution of blood lipids in this large sample of unselected type 2 diabetic patients challenges the previous conception of diabetic dyslipidemia, and calls for new studies to explain the roles of LDL-C and HDL-C as strong cardiovascular risk factors in type 2 diabetes.

摘要

背景

2型糖尿病和糖尿病血脂异常是心血管疾病的高危状况。然而,糖尿病患者血脂分布的描述并非基于人群调查。本研究的目的是描述来自瑞典国家糖尿病登记处的大量未经选择的患者样本中的糖尿病血脂异常情况。

方法

对75048例2型糖尿病患者(57%为男性)的血脂谱和临床特征进行了研究。

结果

3.4%的患者出现明显的高甘油三酯血症(甘油三酯>4.0mmol/L)。女性的总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和非高密度脂蛋白胆固醇(Non-HDL-C)一般较高,而LDL-C/HDL-C和Non-HDL-C/HDL-C比值较低。接受降脂药物治疗的患者平均TC、LDL-C以及HDL-C值较低,而甘油三酯高于未治疗的患者。在未接受降脂药物治疗的患者中,所有血脂在女性中随年龄增长而升高,在男性中(HDL-C除外)随年龄增长而降低。LDL-C/HDL-C比值≥3的患者年龄稍小,较少使用降脂药物,冠心病或中风病史也不常见。

结论

在这个大量未经选择的2型糖尿病患者样本中血脂的分布挑战了以往对糖尿病血脂异常的认识,并呼吁开展新的研究来解释LDL-C和HDL-C作为2型糖尿病中强大心血管危险因素的作用。

相似文献

1
Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register.75048例2型糖尿病患者的血脂情况:一项基于瑞典国家糖尿病登记处的人群调查。
Eur J Cardiovasc Prev Rehabil. 2011 Feb;18(1):97-105. doi: 10.1097/HJR.0b013e32833ba61e.
2
Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.法国全科医疗中接受降脂治疗患者的混合性血脂异常:一项观察性研究。
Clin Ther. 2007 Aug;29(8):1671-81. doi: 10.1016/j.clinthera.2007.08.003.
3
Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs.接受降血脂药物治疗的患者中低高密度脂蛋白胆固醇血症和高甘油三酯血症的患病率。
Arch Cardiovasc Dis. 2009 Jan;102(1):43-50. doi: 10.1016/j.acvd.2008.06.021. Epub 2009 Jan 25.
4
Residual dyslipidaemia after statin treatment in France: Prevalence and risk distribution.法国他汀类药物治疗后的残余血脂异常:流行情况和风险分布。
Arch Cardiovasc Dis. 2010 May;103(5):302-9. doi: 10.1016/j.acvd.2010.04.003. Epub 2010 Jun 4.
5
[Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].[西班牙2型糖尿病无心血管疾病人群血脂异常的治疗方法及目标达成情况]
Endocrinol Nutr. 2011 Jun-Jul;58(6):283-90. doi: 10.1016/j.endonu.2011.03.005.
6
Diabetic dyslipidemia: extending the target beyond LDL cholesterol.糖尿病血脂异常:将治疗目标扩展至低密度脂蛋白胆固醇之外。
Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S20-4. doi: 10.1097/01.hjr.0000368195.09485.17.
7
[Dislypidemia as a risk factor for cardiovascular disease].[血脂异常作为心血管疾病的一个危险因素]
Rev Med Chir Soc Med Nat Iasi. 2010 Oct-Dec;114(4):977-81.
8
Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.低高密度脂蛋白胆固醇在接受血脂异常治疗的欧洲2型糖尿病患者中很常见:一项泛欧洲调查的数据
Diabet Med. 2007 Apr;24(4):388-91. doi: 10.1111/j.1464-5491.2007.02111.x. Epub 2007 Feb 28.
9
A case report of a diabetic woman with very low HDL cholesterol.一名糖尿病女性患者高密度脂蛋白胆固醇水平极低的病例报告。
J Clin Lipidol. 2010 Mar-Apr;4(2):133-5. doi: 10.1016/j.jacl.2010.01.003. Epub 2010 Jan 29.
10
Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.外周动脉疾病患者的血脂异常诊断与治疗被忽视。
Scand Cardiovasc J. 2007 Jun;41(3):138-41. doi: 10.1080/14017430601187751.

引用本文的文献

1
The Impact of Aerobic Exercise on HDL Quantity and Quality: A Narrative Review.有氧运动对高密度脂蛋白数量和质量的影响:一项叙述性综述。
Int J Mol Sci. 2023 Feb 28;24(5):4653. doi: 10.3390/ijms24054653.
2
A community based cross sectional study on the prevalence of dyslipidemias and 10 years cardiovascular risk scores in adults in Asmara, Eritrea.一项基于社区的横断面研究,评估了厄立特里亚阿斯马拉成年人血脂异常的流行情况和 10 年心血管风险评分。
Sci Rep. 2022 Apr 2;12(1):5567. doi: 10.1038/s41598-022-09446-9.
3
The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity.
心脏脂肪酸氧化对糖尿病心肌病严重程度的影响。
Cells. 2021 Nov 21;10(11):3259. doi: 10.3390/cells10113259.
4
Cardiovascular disease in diabetes, beyond glucose.糖尿病与心血管疾病:不止于血糖。
Cell Metab. 2021 Aug 3;33(8):1519-1545. doi: 10.1016/j.cmet.2021.07.001. Epub 2021 Jul 21.
5
Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus.新诊断 2 型糖尿病患者的降脂药物临床处方和治疗目标达标情况。
BMJ Open Diabetes Res Care. 2021 Feb;9(1). doi: 10.1136/bmjdrc-2020-001891.
6
Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden.在瑞典,2 型糖尿病患者的心血管事件和死亡率与降脂药物的续药和指南依从性相关。
BMJ Open Diabetes Res Care. 2019 Apr 8;7(1):e000639. doi: 10.1136/bmjdrc-2018-000639. eCollection 2019.
7
Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.2型糖尿病患者及伴有风险的低密度脂蛋白胆固醇患者的降脂药物处方:一项基于瑞典国家糖尿病登记处的全国性指南依从性研究
BMC Health Serv Res. 2018 Nov 28;18(1):900. doi: 10.1186/s12913-018-3707-4.
8
Is the ratio of apoB/apoA-1 the best predictor for the severity of coronary artery lesions in Chinese diabetics with stable angina pectoris? An assessment based on Gensini scores.载脂蛋白B/载脂蛋白A-1比值是中国稳定型心绞痛糖尿病患者冠状动脉病变严重程度的最佳预测指标吗?基于Gensini评分的评估。
J Geriatr Cardiol. 2015 Jul;12(4):402-9. doi: 10.11909/j.issn.1671-5411.2015.04.012.
9
Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status.绝经前和绝经后2型糖尿病女性的代谢综合征:绝经前状态保护作用的丧失
J Diabetes Metab Disord. 2014 Nov 23;13(1):102. doi: 10.1186/s40200-014-0102-5. eCollection 2014.
10
Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes Register.降脂治疗在糖尿病患者中的临床应用及疗效观察——来自瑞典国家糖尿病登记处的一项观察性研究。
PLoS One. 2011 Apr 29;6(4):e18744. doi: 10.1371/journal.pone.0018744.